FDA Approves METFORMIN HYDROCHLORIDE EXTENDED RELEASE — TIME CAP LABORATORIES, INC

TIME CAP LABORATORIES, INC. received FDA approval for its ANDA applying generic versions of METFORMIN HYDROCHLORIDE EXTENDED RELEASE, securing a lucrative entry into the insulin sensitizer market and instantly increasing generic competition for the widely prescribed antidiabetic therapy.